Medicare Procedure and Patient Information
2018 Medicare Patient Data
Information about Medicare patients treated by Dr. Daniel L. Long, DO.
| Non-Hispanic White | |
|---|---|
| Black | |
| Hispanic | |
| Asian | |
| Other | |
| Native American |
(No ratings)
Dr. Daniel L. Long, DO is a neurologist in Neenah, WI specializing in neurology (brain & spinal cord disease). He graduated from Des Moines University, College of Osteopathic Medicine in 2014 and has 11 years of experience. Dr. Daniel L. Long, DO is affiliated with ThedaCare and THE NEUROSCIENCE GROUP OF NORTHEAST WISCONSIN SC.
Click on any procedure below to see further details on volume and pricing among Medicare patients.
In 2023, Dr. Daniel L. Long, DO performed more biological response modifier (BRM) therapy, intravenous infusion therapy, and intravenous (IV) chemotherapy procedures for Medicare patients than 95% of providers in related specialties within Wisconsin.
In 2013, Dr. Daniel L. Long, DO performed more blood draw, and phlebotomy for lab tests procedures for Medicare patients than 75% of providers in related specialties within Wisconsin.
Information about Medicare patients treated by Dr. Daniel L. Long, DO.
| Non-Hispanic White | 11 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
The top procedures that Dr. Daniel L. Long, DO treated as a neurologist in Neenah, WI during 2019 were hospital care, inpatient care and blood draw.
Volume of procedures performed by Dr. Daniel L. Long, DO for Medicare patients.
| blood draw | 17 |
|---|---|
| doctor visit | 13 |
| hospital care | 28 |
| inpatient care | 28 |
Information about Medicare patients treated by Dr. Daniel L. Long, DO.
| Male | 28 |
|---|---|
| Female | 41 |
| From 65 to 74 | 23 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 23 |
The most common conditions of Medicare patients that Dr. Daniel L. Long, DO treated during 2019 were high cholesterol, hypertension, stroke and depression.
| Hypertension | 55 |
|---|---|
| High Cholesterol | 61 |
| Stroke | 32 |
| Ischemic Heart Disease | 30 |
| Depression | 30 |
| Chronic Kidney Disease | 29 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 20 |
| Heart Failure | 23 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 28 |
| Dementia | 17 |
| Cancer | 0 |
The top procedures that Dr. Daniel L. Long, DO treated as a neurologist in Neenah, WI during 2020 were hospital care, inpatient care, blood draw and MRI (magnetic resonance imaging).
Volume of procedures performed by Dr. Daniel L. Long, DO for Medicare patients.
| blood draw | 45 |
|---|---|
| brain imaging (neuroimaging) | 19 |
| doctor visit | 133 |
| hospital care | 103 |
| inpatient care | 103 |
| MRI (magnetic resonance imaging) | 19 |
Information about Medicare patients treated by Dr. Daniel L. Long, DO.
| Male | 63 |
|---|---|
| Female | 89 |
| Non-Hispanic White | 138 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 53 |
|---|---|
| From 75 to 84 | 21 |
| 85 and over | 13 |
| Less than 65 | 65 |
The most common conditions of Medicare patients that Dr. Daniel L. Long, DO treated during 2020 were hypertension, high cholesterol, depression and chronic kidney disease.
| Hypertension | 60 |
|---|---|
| High Cholesterol | 55 |
| Stroke | 32 |
| Ischemic Heart Disease | 29 |
| Depression | 41 |
| Chronic Kidney Disease | 34 |
| Asthma | 9 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 14 |
| Heart Failure | 18 |
| Chronic Obstructive Pulmonary Disease | 13 |
| Diabetes | 26 |
| Dementia | 16 |
| Cancer | 9 |
The top procedures that Dr. Daniel L. Long, DO treated as a neurologist in Neenah, WI during 2021 were blood draw, hospital care, inpatient care and MRI (magnetic resonance imaging).
Volume of procedures performed by Dr. Daniel L. Long, DO for Medicare patients.
| biological response modifier (BRM) therapy | 28 |
|---|---|
| blood draw | 103 |
| brain imaging (neuroimaging) | 41 |
| chemotherapy | 28 |
| doctor visit | 212 |
| hospital care | 85 |
| inpatient care | 85 |
| minimally invasive procedures | 28 |
| MRI (magnetic resonance imaging) | 60 |
| spinal procedures | 19 |
Information about Medicare patients treated by Dr. Daniel L. Long, DO.
| Male | 70 |
|---|---|
| Female | 131 |
| Non-Hispanic White | 188 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 81 |
|---|---|
| From 75 to 84 | 26 |
| 85 and over | 20 |
| Less than 65 | 74 |
The most common conditions of Medicare patients that Dr. Daniel L. Long, DO treated during 2021 were high cholesterol, hypertension, depression and chronic kidney disease.
| Hypertension | 51 |
|---|---|
| High Cholesterol | 56 |
| Stroke | 27 |
| Ischemic Heart Disease | 24 |
| Depression | 40 |
| Chronic Kidney Disease | 32 |
| Asthma | 8 |
| Osteoperosis | 9 |
| Atrial Fibrilation | 12 |
| Heart Failure | 12 |
| Chronic Obstructive Pulmonary Disease | 9 |
| Diabetes | 24 |
| Dementia | 16 |
| Cancer | 7 |
The top procedures that Dr. Daniel L. Long, DO treated as a neurologist in Neenah, WI during 2022 were blood draw, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.
Volume of procedures performed by Dr. Daniel L. Long, DO for Medicare patients.
| biological response modifier (BRM) therapy | 64 |
|---|---|
| blood draw | 107 |
| brain imaging (neuroimaging) | 32 |
| chemotherapy | 64 |
| doctor visit | 299 |
| hospital care | 14 |
| inpatient care | 14 |
| minimally invasive procedures | 102 |
| MRI (magnetic resonance imaging) | 32 |
Information about Medicare patients treated by Dr. Daniel L. Long, DO.
| Male | 75 |
|---|---|
| Female | 154 |
| Non-Hispanic White | 217 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 104 |
|---|---|
| From 75 to 84 | 40 |
| 85 and over | 22 |
| Less than 65 | 63 |
The most common conditions of Medicare patients that Dr. Daniel L. Long, DO treated during 2022 were high cholesterol, hypertension, depression and stroke.
| Hypertension | 61 |
|---|---|
| High Cholesterol | 65 |
| Stroke | 29 |
| Ischemic Heart Disease | 19 |
| Depression | 37 |
| Chronic Kidney Disease | 22 |
| Asthma | 11 |
| Osteoperosis | 16 |
| Atrial Fibrilation | 19 |
| Heart Failure | 11 |
| Chronic Obstructive Pulmonary Disease | 7 |
| Diabetes | 20 |
| Dementia | 9 |
| Cancer | 14 |
The top procedures that Dr. Daniel L. Long, DO treated as a neurologist in Neenah, WI during 2023 were blood draw, chemotherapy, biological response modifier (BRM) therapy and minimally invasive procedures.
Volume of procedures performed by Dr. Daniel L. Long, DO for Medicare patients.
| biological response modifier (BRM) therapy | 59 |
|---|---|
| blood draw | 75 |
| brain imaging (neuroimaging) | 24 |
| chemotherapy | 59 |
| doctor visit | 261 |
| hospital care | 59 |
| inpatient care | 59 |
| minimally invasive procedures | 59 |
| MRI (magnetic resonance imaging) | 24 |
Information about Medicare patients treated by Dr. Daniel L. Long, DO.
| Male | 75 |
|---|---|
| Female | 129 |
| Non-Hispanic White | 191 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 96 |
|---|---|
| From 75 to 84 | 31 |
| 85 and over | 14 |
| Less than 65 | 63 |
The most common conditions of Medicare patients that Dr. Daniel L. Long, DO treated during 2023 were high cholesterol, hypertension, depression and stroke.
| Hypertension | 60 |
|---|---|
| High Cholesterol | 66 |
| Stroke | 26 |
| Ischemic Heart Disease | 22 |
| Depression | 39 |
| Chronic Kidney Disease | 23 |
| Asthma | 10 |
| Osteoperosis | 14 |
| Atrial Fibrilation | 19 |
| Heart Failure | 15 |
| Chronic Obstructive Pulmonary Disease | 11 |
| Diabetes | 23 |
| Dementia | 13 |
| Cancer | 12 |
Volume of procedures performed by Dr. Daniel L. Long, DO for Medicare patients.
The highest averages for the top procedures that Dr. Daniel L. Long, DO treated as a neurologist in Neenah, WI were blood draw, minimally invasive procedures, hospital care and inpatient care.
| biological response modifier (BRM) therapy | 50 |
|---|---|
| blood draw | 69 |
| brain imaging (neuroimaging) | 29 |
| chemotherapy | 50 |
| doctor visit | 183 |
| hospital care | 57 |
| inpatient care | 57 |
| minimally invasive procedures | 63 |
| MRI (magnetic resonance imaging) | 33 |
| spinal procedures | 19 |
Information about Medicare patients treated by Dr. Daniel L. Long, DO.
| Male | 51 |
|---|---|
| Female | 90 |
| Black / African American | 0 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 124 |
| Native American / Alaskan Native | 0 |
| Hispanic | 0 |
| Other | 0 |
| 75 to 84 | 19 |
|---|---|
| 85 and over | 11 |
| Less than 65 | 48 |
| 65 to 74 | 59 |
The highest averages of the most common conditions of Medicare patients that Dr. Daniel L. Long, DO treated were high cholesterol, hypertension, depression and stroke.
| Hypertension | 47 |
|---|---|
| High Cholesterol | 50 |
| Stroke | 24 |
| Ischemic Heart Disease | 20 |
| Depression | 31 |
| Chronic Kidney Disease | 23 |
| Asthma | 6 |
| Osteoporosis | 6 |
| Heart Failure | 13 |
| Chronic Obstructive Pulmonary Disease | 6 |
| Diabetes | 20 |
| Atrial Fibrillation | 14 |
| Cancer | 7 |
| Dementia | 11 |
Dr. Daniel L. Long, DO graduated from Des Moines University, College of Osteopathic Medicine in 2014. He completed residency at Lansing - Sparrow Health System. He is certified by the Neurology, American Board of Psychiatry & Neurology and has a state license in Wisconsin.
Medical School: Des Moines University, College of Osteopathic Medicine (2014)
Residency: Lansing - Sparrow Health System (2018)
Board Certification: Neurology, American Board of Psychiatry & Neurology (2018)
Licensed In: Wisconsin
Dr. Daniel L. Long, DO is associated with these hospitals and organizations:
Dr. Daniel L. Long, DO does not have any reviews yet, be the first to leave a review of Dr. Daniel L. Long, DO here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Daniel L. Long, DO. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| EMD Serono, Inc. |
$287,368
Mavenclad $249,798 |
Evobrutinib $9,600 |
Rebif $14 |
$27,957 |
||
|---|---|---|---|---|---|---|
| Biogen, Inc. |
$104,123
Vumerity $40,838 |
TYSABRI $39,345 |
TECFIDERA $12,281 |
ZINBRYTA $128 |
AVONEX $101 |
Other $11,430 |
| TG Therapeutics, Inc. |
$52,793
BRIUMVI $50,732 |
$2,061 |
||||
| Genentech USA, Inc. |
$52,689
OCREVUS $50,256 |
Enspryng $118 |
Ocrevus Zunovo $53 |
$2,263 |
||
| Alexion Pharmaceuticals, Inc. |
$40,636
ULTOMIRIS $23,852 |
SOLIRIS $4,893 |
$11,891 |
|||
| Other |
$84,720
ZEPOSIA $51,189 |
AUBAGIO $6,803 |
MAYZENT $5,467 |
UPLIZNA $4,070 |
Nityr $1,060 |
Other $16,132 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $487,733 |
|---|---|
| Consulting Fee | $66,834 |
| Travel and Lodging | $41,252 |
| Food and Beverage | $22,074 |
| Honoraria | $3,600 |
| Other | $835 |
Dr. Daniel L. Long, DO has received 207 research payments totaling $171,586.
Dr. Daniel Long is a specialist in neurology (brain & spinal cord disease). He is affiliated with ThedaCare. He attended medical school at Des Moines University, College of Osteopathic Medicine.